Skip to content

Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic

Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03780556
Enrollment
120
Registered
2018-12-19
Start date
2016-01-02
Completion date
2018-05-31
Last updated
2018-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Colic

Keywords

Renal pain, lornoxicam, pethidine, emergency room, ketamine

Brief summary

Patients with acute renal colic divided into 2 groups. Group L administered ornoxicam and Group P administered pethidine and VAS was recorded for both groups.

Detailed description

Prospective, randomized, double blind clinical study including 120 patients with acute renal pain admitted in emergency department. They were randomly assigned to one of two groups using a computer-generated table. Group L received lornoxicam 8 mg IV plus 0.15 mg.kg-1 ketamine and Group P received pethidine 50 mg IV. Parameters were observed at baseline and after 0, 15, 30, 45 and 1 hour of drug treatment. The efficacy of the drug was measured by observing: patient rated pain, time to pain relief, rate of pain recurrence, the need for rescue analgesia, adverse events and functional status.

Interventions

DRUGLornoxicam and mepridine

compare the effect of each to control pain

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients, who did not administer any analgesics at least within the last two hours. - - * Patients aged between 20-60 years.

Exclusion criteria

* Patients with previous renal surgery * liver and renal failure * hypersensitivity to lornoxicam, ketamine and pethidine, history of peptic ulcer, * gastrointestinal bleeding and perforation, * hypertensive and history of cardiac diseases * pregnancy and lactation and * urine examination showing more than 5 leukocytes suggestive of pyuria. * patients with hyperthyroidism are excluded

Design outcomes

Primary

MeasureTime frameDescription
Change in pain feeling0hours, 1hour,2hours,3hours,4hours after drug administration in both groupsWe assess this through Visual analogue scale score to assess pain due to renal colic, number 10 means maximum pain feeling and 0 means no pain at all.
No need for more analgesicsRegistration of analgesic needed for 12h after the attackRescue analgesics administration

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026